Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2022 08:00 ET | Source: Valitor, Inc.

Valitor Announces the Closing of its Series B Financing and Names Steven Lo as Chief Executive Officer

BERKELEY, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that it has closed a Series B...
October 05, 2022 01:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022

New positive data from Evrysdi, a treatment for spinal muscular atrophy (SMA), a progressive neuromuscular disease that can be fatalData from the gene therapy programme for Duchenne muscular dystrophy...
October 04, 2022 08:36 ET | Source: AC Immune SA

AC Immune Opens New Centers in Phase 1b/2 Trial Evaluating ACI-24 Targeting Abeta in Alzheimer’s Disease and Down Syndrome

Interim analysis expected around year-end 2022, informing Phase 2 startTrial progressing with regulatory clearances in the UK and also now in SpainPlanned submission of U.S. Investigational New Drug...
October 04, 2022 01:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche receives FDA approval for first companion diagnostic to identify patients with HER2 low metastatic breast cancer eligible for ENHERTU

Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2. These patients with HER2 low status may now be eligible for a targeted treatment, which could...
October 03, 2022 08:00 ET | Source: Codexis, Inc.

Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer

REDWOOD CITY, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment...
October 03, 2022 01:00 ET | Source: F. Hoffmann-La Roche Ltd

[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche: Wechsel in der Konzernleitung im Januar 2023

Basel, 3. Oktober 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) gab heute bekannt, dass Matt Sause (45), derzeit Leiter der Region Nordamerika von Roche Diagnostics, ab dem 1. Januar 2023 CEO von Roche...
October 03, 2022 01:00 ET | Source: F. Hoffmann-La Roche Ltd

[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Corporate Executive Committee in January 2023

Basel, 3 October 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Matt Sause (45), currently Head of Roche Diagnostics’ North America Region, will become CEO Roche Diagnostics and a...
September 30, 2022 07:00 ET | Source: Biogen Inc.

Biogen Announced EMA Filing Acceptance of BIIB800, A Biosimilar Candidate Referencing RoACTEMRA® (tocilizumab)

CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for...
September 29, 2022 10:04 ET | Source: ReportLinker

The Global RNA Analysis Market size is expected to reach $28 billion by 2028, rising at a market growth of 15.6% CAGR during the forecast period

New York, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global RNA Analysis Market Size, Share & Industry Trends Analysis Report By Product, By...
September 28, 2022 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Strengthens Leadership Team with Two New Key Hires

SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering,...